Literature DB >> 1899443

Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis.

V B Swope1, Z Abdel-Malek, L M Kassem, J J Nordlund.   

Abstract

Interleukin (IL)-1 alpha, IL-6, and tumor necrosis factor (TNF)-alpha are epidermal cytokines that produce many similar biologic effects. We have investigated the possibility that these cytokines act as regulators of melanization and proliferation of cultured normal human melanocytes (NHM). All three cytokines elicited a dose-dependent decrease in the activity of the enzyme tyrosinase after 48 h of treatment. IL-1 alpha had the greatest inhibitory effect, resulting in a 22% inhibition of tyrosinase activity at a concentration of 3 x 10(-14) M. An equivalent effect was elicited by 4 x 10(-11) M IL-6 and 10(-11) M TNF-alpha. All three cytokines also inhibited melanocyte proliferation, as measured by a decrease in the rate of 3H-thymidine incorporation and an increase in doubling time. IL-1 alpha at 6 x 10(-14) M, 6 x 10(-13) M, and 3 x 10(-12) M, TNF-alpha at 10(-10) M, 10(-9) M, and 10(-8) M, and IL-6 at 4 x 10(-10) and 1.2 x 10(-9) M produced a dose-dependent inhibition of 3H-thymidine incorporation. The effects of IL-1 alpha, TNF-alpha, and IL-6 were cytostatic, not cytotoxic, because melanocytes remained viable following several treatments with the cytokines. Also, melanocytes treated with IL-1 alpha and TNF-alpha recovered and resumed proliferation after cessation of treatment. These effects of IL-1 alpha, IL-6 and TNF-alpha do not seem to be mediated by stimulation of eicosanoid production, because inhibition of arachidonic acid (AA) metabolism by indomethacin, a cyclooxygenase inhibitor, and nordihydroguaiaretic acid, a lipoxygenase inhibitor, did not reverse the inhibitory effects on either proliferation or tyrosinase activity of NHM. This is the first demonstration that NHM respond to epidermal cytokines, and suggests a role for paracrine and possibly autocrine regulation of melanocytes by immune modulators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899443     DOI: 10.1111/1523-1747.ep12460991

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

Review 1.  Pigmented human skin equivalent--as a model of the mechanisms of control of cell-cell and cell-matrix interactions.

Authors:  K Nakazawa; M Kalassy; F Sahuc; C Collombel; O Damour
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis.

Authors:  G Kolde; K Schulze-Osthoff; H Meyer; J Knop
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.

Authors:  I Cornil; D Theodorescu; S Man; M Herlyn; J Jambrosic; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  UV-B radiation induces macrophage migration inhibitory factor-mediated melanogenesis through activation of protease-activated receptor-2 and stem cell factor in keratinocytes.

Authors:  Akiko Enomoto; Yoko Yoshihisa; Takako Yamakoshi; Mati Ur Rehman; Osamu Norisugi; Hiroshi Hara; Kenji Matsunaga; Teruhiko Makino; Jun Nishihira; Tadamichi Shimizu
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment.

Authors:  Luisa Di Costanzo; Emanuele Scala; Giuseppina Caiazzo; Serena Lembo; Rita Marino; Matteo Megna; Angela Patrì; Roberta Di Caprio; Anna Balato
Journal:  Exp Ther Med       Date:  2019-09-17       Impact factor: 2.447

Review 6.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

7.  Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma.

Authors:  Verena von Felbert; Francisco Córdoba; Jakob Weissenberger; Claudio Vallan; Masashi Kato; Izumi Nakashima; Lasse Roger Braathen; Joachim Weis
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 8.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

9.  Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.

Authors:  K Krasagakis; C Garbe; J Eberle; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes.

Authors:  Hee-Young Park; Christina Wu; Mina Yaar; Christina M Stachur; Marita Kosmadaki; Barbara A Gilchrest
Journal:  Int J Cell Biol       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.